We invite you to participate in this "offline" Forum Discussion led by Brian Balin (Philadelphia College of Osteopathic Medicine). This discussion will extend our previously held live discussion on the Pathogen Hypothesis of Alzheimer Disease. Take advantage of this more leisurely format to express your ideas in depth. Please contact us with questions, comments, critiques, and kudos. We will post your commentaries and forward them to other participants for their responses.


Background Text
By Brian Balin

Arguments put forth for the importance of pathogens, as opposed to genetics, in chronic diseases of aging, including neurological ones, are reminiscent of the perennial debate over nature versus nurture in human development. Which has the greatest influence: something inherent or something extraneous? The answer, obviously, lies in both. Yet a disproportionate amount of research effort and funding on the causes of Alzheimer disease is directed towards finding genes for late-onset AD. Even epidemiological studies focus on factors such as nutrition, medications, and lifestyle, and largely overlook the possibility of infection. However, research by my laboratory and a handful of others suggests that pathogens may play a more important role—more so than genetics, perhaps—than some may be willing to believe.

The environmental influences of the microbial world in chronic diseases of aging cannot be dismissed. Time and again, science and medicine have been rocked by the discovery of infectious processes where none was expected. In just the last quarter of the twentieth century we have seen dramatic instances of new infectious diseases, including AIDS, and have come to realize that maladies such as gastric ulcers, once thought to result from bad diet, bad lifestyle, or simply bad genes, can actually be caused by microorganisms.

With the sequencing of the human genome, the stage is set for enormous breakthroughs in our understanding of genetics and disease. However, what is often missed, or given little consideration, is that we are not pure organisms. The microbial world insinuates into our existence, often, as retroviruses can, by influencing our genetic makeup. And just as we cannot discount the importance of that makeup—because it can predispose individuals to either resist or succumb to disease—likewise, we cannot discount the fact that acute and chronic infectious diseases are today the major contributors to the morbidity and mortality of the world's human and animal populations.

While acute infectious disease is often readily diagnosed, chronic infection is a different matter. Paul Ewald points out in his book Plague Time that in the absence of an acute phase of disease, infectious causation is either dismissed or not even considered. He goes on to examine how the scientific and medical communities have considered infectious disease in the last two centuries. During the last quarter of the nineteenth century, all diseases of infectious origin were primarily acute, that is, the sufferers had obvious symptoms shortly after infection. In contrast, in the last quarter of the twentieth century, most newly identified human infectious diseases have been of a chronic nature. Ewald terms these the "Stealth Infections." Among the chronic diseases that Ewald proposes may be microbial in origin are cancer, atherosclerosis, and Alzheimer disease. The key arguments in support of the "pathogen hypothesis" have been detailed on the Alzforum [see "The Pathogen Hypothesis" and "Viruses and Dementia, and the Role of Apolipoprotein E (ApoE)"]. In this discussion, I would like to invite colleagues to debate specific points raised against the pathogen hypothesis. Specifically, I encourage colleagues to think creatively about how to reconcile the role of microbial pathogens with genetics and known molecular pathways involved in Alzheimer disease.

Discussion Topics

Objection: ApoE proves that genetics is critically important in late-onset AD.

Balin: Paul Ewald presents a very intriguing argument with regard to chronic disease. He states that "chronic diseases, if they are common and damaging, must be powerful eliminators of any genetic instruction that may cause them." Thus, he goes on to argue that the only factor capable of staying ahead of natural selection is pathogens, which can mutate their way rapidly around any genetic adaptations. In essence, we are in a genetic arms race against microbes that we cannot win. Mathematical models based on this concept imply that nongenetic factors are almost entirely responsible for chronic degenerative diseases.

What, then, about ApoE? Ewald argues that genetic causes of chronic disease will persist only if a genetic instruction provides a compensating benefit. For example, sickle cell anemia is caused by a genetic mutation that, in heterozygotes, protects against malaria, which kills millions worldwide each year. The relatively few individuals who inherit two copies of the sickle cell gene suffer a painful and crippling disease, but the gene has persisted because it contributes significantly to the survival of the more numerous heterozygotes. It has been hypothesized that the ApoE4 allele evolved late in human evolution and may have conferred a benefit in younger individuals, perhaps by modifying lipid metabolism as the amount of animal fats in the diet increased. The e4 allele might be one that is beneficial during reproductive years but becomes a detriment in old age.

ApoE4 may confer increased susceptibility to infection in Alzheimer disease. Studies by Dobson and Itzhaki, 1999, demonstrated that AD patients with the e4 allele were more likely to also harbor HSV1. Furthermore, in a recent study by Gerard et al., 2005, the bacterial load of Chlamydia pneumoniae in the Alzheimer brain was significantly higher in the ApoE4-bearing AD brain tissues, as compared to the AD brain tissues not expressing the e4 allele. Is it possible that HSV1, Chlamydia pneumoniae, and possibly other infectious microbes could be hijacking molecules for cholesterol delivery to enter the brain? This scenario offers a novel interpretation for how a genetic risk factor and infectious agent might interact to cause disease.

Objection: The risk for late-onset AD is clearly heritable, even in individuals with the ApoE4 allele, so there must be other risk-factor genes waiting to be discovered.

Balin: No doubt, with further analysis, other risk-factor genes will be discovered. However, studies of monozygotic twin populations clearly demonstrate that genetic factors account only partially for an increased risk of AD. Genes predispose individuals to AD, but environmental influences must come into play to ultimately cause disease. Just as previously mentioned, there are a multitude of examples that suggest that the combination of a pathogen and genetic susceptibility can result in disease.

Objection: Most of us harbor pathogens in the CNS with no ill effect.

Balin: There is a presumption that the presence of infectious agents in tissues is not harmful if there is no obvious acute or reactive process. Any microbial invasion of the human central nervous system that results in acute, chronic, and/or permanent residence cannot be good. Of all the tissues in the body, one would expect the central nervous system, which controls our entire being, to be most "sterile." Ironically, the central nervous system is the one site in the body where infectious agents can persist over a long time because in this part of the body, they can evade immune surveillance by the body's defense system.

However, this begs the question of the brain's "internal immune surveillance" that is accomplished principally by microglia and astroglia. Chronic and/or persistent "turn-on" of these cells due to the presence of infection or products of infection would not be healthy for nerve cells. One could envision a tissue response by the brain that would result in chronic degenerative damage. A perfect analogy is tuberculosis in lung tissue in which chronic inflammation due to a persistent stimulus (i.e., mycobacterium or products of mycobacterium in the macrophages) results in granuloma formation, a focus of inflammation around damaged or dead, necrotic lung tissue. Could the well-circumscribed dense-core amyloid plaque be a comparable "granuloma" of the brain?

Objection: Many neurologists and neuropathologists will object that "since most people have viruses in their nervous systems, the viruses must not be contributing to disease."

Balin: This argument is flawed. Consider Helicobacter pylori infection in the stomachs of human populations. This organism has been proven in the last two decades of the twentieth century to cause gastric and peptic ulcers, gastric cancer, and mucosal-associated lymphoid tissue tumors in the stomach. Approximately 3.5 billion people are infected with this organism, but only 10 percent show obvious disease. Are we to believe that because such a large population is infected with this organism, but only a small percentage actually fall ill, that the presence of the organism in the gut is of little significance? Obviously, this is not the case.

And, there are parallels in the central nervous system! Herpes viruses that infect neurons are known to cause annoying chronic problems such as cold sores and shingles. Other pathogens are known to cause or contribute to more significant problems such as Bell's palsy and Guillain-Barre syndrome. But there may be still others that may trigger even more severe disease pathogenesis. For example, the autoimmune responses that lead to multiple sclerosis might be triggered by infection, and AIDS dementia results from long-term infection with the HIV-1 virus. And, it just so happens, that HIV-dementia appears to be worsened in those patients who express the ApoE4 allele (Corder et al., 1998)!

Objection: If pathogens cause AD, why don't we see AD brains full of viruses or other microbes?

Balin: Microbes have many tricks for hiding out in tissues. Viruses, for example, can insinuate themselves into host cells' genes and become invisible. Chlamydia pneumoniae is an extremely interesting organism and candidate for numerous diseases. This bacterium is endocytosed into vacuoles within a variety of cell types and may be retained in certain cells indefinitely. Our own studies have determined that infection by this organism into neuroblastoma cells in culture confers an antiapoptotic effect on the cells, thus ensuring infection in a chronic to persistent state. Difficulties in recognizing this type of infection are a major challenge. Changes in gene and antigen expression with persistency have led, at times, to the undetectability of the organism in tissues and culture samples. Furthermore, homology of some bacterial proteins with eukaryotic proteins may result in antigenic mimicry that can incite an autoimmune response without a clearly identified or identifiable infectious component. These are just a few reasons why associating infection with chronic disease or proving that infection is causing chronic disease is so difficult.

Objection: By what mechanism can chronic infection result in a chronic degenerative disease?

Balin: Chronic diseases can result from direct impact of infection on the genetics of the system. For example, cervical cancer, a chronic disease, is caused by the human papilloma virus (HPV). Different strains of this virus code for proteins that directly impact two proteins, the retinoblastoma tumor suppressor protein, and the p53 protein, which is important in DNA repair. The viral proteins block the ability of the eukaryotic proteins to apply breaks to the cell cycle, thus leading to cellular proliferation and cancer.

Another possible mechanism is autoimmunity such as mentioned above. A microbe may express genes that are molecular mimics of a human protein (say, Aß). The body mounts an immune attack on the microbe, which is cleared from the scene. Rheumatic heart disease is a familiar example of how this could occur. Years later, some trigger (a new infection, or overexpression of Aß?) results in an immune attack against the endogenous protein and causes severe tissue damage.

Objection: People have searched in good faith, but the data are not convincing. Ergo, there's nothing to this hypothesis.

Balin: Several studies, including our own, have reported a remarkably strong association between a microbe and AD, but other studies have not shown such an association. There are numerous reasons why there are discrepancies in the different studies. These include tissue sampling, use of different polymerase chain reaction (PCR) primers and probes, and different antibody probes to different antigenic determinants of the organism at different stages of infection. We must work on standardizing approaches to resolve some of these issues. Numerous laboratories have applied real-time PCR approaches in this effort. However, even in these instances, newer findings on gene expression and gene modifications found in microorganisms are clouding these approaches. Thus, numerous techniques and collaborative approaches are required to objectively address these issues prior to ruling out infectious risk and/or causation of chronic diseases. The solution is still unfolding in the laboratory, where increasingly sophisticated techniques are being used to discover if infection is involved in the pathogenic processes. Evolution of newer techniques and development of animal models of infection are some of the key reasons we can now more efficiently investigate pathogen causation in chronic diseases.

Objection: Why mess around with microbes when there are other, more compelling ideas, such as the amyloid cascade hypothesis, with so much more supporting data, including persuasive genetic findings on the cause of early-onset familial AD and the increased risk of LOAD associated with ApoE4?

Balin: Until we can clearly determine the cause of AD and other neurodegenerative diseases, as well as many other chronic diseases, infection must be included as a hypothesis. In the history of medicine and science, this has proven to be and continues to be the greatest determinant of disease. Researchers must ask themselves the following questions: 1) Has all previous work on a given chronic disease of aging demonstrated that infection is not involved in the disease? 2) Have we put enough resources behind the investigators and investigations studying infection in chronic diseases of aging to rule out infection as causing the problems? And last, but not least, 3) do we currently have enough knowledge of infectious diseases in chronic conditions to proclaim that chronic infection does not cause chronic disease? If the answers to any of these questions is no, then pathogen involvement in chronic diseases of aging has to be given high priority for consideration.

The possibility that treatable common microbial infections are contributing to the global crisis of Alzheimer disease has implications for public health that are too important to ignore. A thorough review of many of the issues discussed here can be found through the American Academy of Microbiology. A report entitled "Microbial Triggers of Chronic Human Illnesses" was compiled from a colloquium held in June 2004. This report highlights many features relevant to this discussion. For example, two sections report on host factors and microbial factors that contribute to illness. Host factors that are considered are: genetics, concomitant infections, age, dose, gender, hormonal factors, immune status, nutritional status, behavioral factors, and exposure to non-infectious agents. Microbial factors considered are: viral or infectious genetic integration into host genome, latency factors, ability to bind to mucosal surfaces or other tissues, characteristics of the target organ, high mutation rate, and immune evasion. In addition, the report highlights currently available techniques for the detection of pathogens with an analysis of the technical strength and weakness.

In summary, this report provides excellent insight into current strategies and the required needs for addressing microbial triggers of chronic illnesses such as Alzheimer disease.


  1. The background article by Brian Balin on the possible microbial cause of Alzheimer disease (AD) and, possibly, other degenerative diseases is intriguing and I think the microbial origin must be taken into consideration at least as a possible con-cause in some late-onset AD (LOAD) forms. However, I would like to add a couple of objections to those reported in the background article.

    1. The amyloid hypothesis of AD and other degenerative diseases is currently largely accepted and supported by an increasing number of data. A relevant fraction of these data arise from studies carried out on genetically modified or transgenic animals in which researchers have been able to reproduce most of the pathological, histological, and behavioral symptoms of AD, but also of other neurodegenerative diseases of amyloid type such as Parkinson disease (PD) and triplet expansion diseases. Of course, the body of these data does not exclude that in some cases, AD and other degenerative diseases may have a microbial cause, but in my opinion it supports the notion that structurally modified proteins may by themselves be sufficient to trigger the complex chain of events eventually leading to cell death and, later, to the appearance of the clinical signs. I agree that LOAD must rely on a number of genetic, lifestyle, and environmental (possibly including pathogens) factors, but I am not convinced that neurodegeneration must necessarily involve pathogens.

    2. The direct cytotoxic effects of amyloid aggregates (mainly the prefibrillar forms) have largely been demonstrated in cultured cells and in animal tissues. Similarly, the central importance of cellular responses to stress, such as the unfolded protein response (UPR) and heat shock response (HSR), leading to the appearance of misfolded/unfolded proteins as well as the role of clearing machineries such as the ubiquitin-proteasome and the endoplasmic reticulum-associated degradation (ERAD) pathways is well documented. Actually, a number of familial forms of AD, PD, and other neurodegenerative diseases have been linked to specific genotypes involving mutations of proteins performing various roles at these levels. Finally, reports are increasing on degenerative conditions where mutant proteins with enhanced tendency to aggregate—other than those classically involved in amyloidoses—are present in the affected tissues. In my opinion, when a mutant protein with enhanced tendency to aggregate is expressed in a tissue where we find amyloid aggregates and clinical signs of degeneration, it allows us to reasonably conclude, at least in familial amyloidoses, that direct causes other than those associated with protein misfolding and aggregation are not at work.

  2. Brian Balin has written his Challenge so impressively, in particular stressing the insidious (though sporadic) nature of stealth microorganisms, that there is little to add except a few hopefully apposite points. Apropos of the extraordinary resistance of many people to the possibility that microorganisms might be involved in certain chronic diseases, this had an early start: In 1872, Louis Pasteur's theory of germs was derided as "ridiculous fiction" by a French professor of physiology! Of course, it is particularly difficult to show that microorganisms are involved in diseases that occur late in life, probably many years after the initial infection. Brian mentioned the reluctance (which lasted 12 years) to accept that a bacterium is involved in stomach ulcers. Similar problems were faced by researchers, such as Epstein and Barr, who proposed a viral role in certain cancers, and by Gajdusek in his research on kuru. All these are now highly respectable concepts.

    Brian stressed another problem: That many are unaware of the workings of microorganisms, and especially the basic fact that many organisms infect vastly more people than they affect. This is particularly so in the case of the common bacteria H. pylori, and Mycobacterium tuberculosis and the common viruses, Epstein-Barr virus, herpes simplex virus type 1 (HSV1), all of which infect huge numbers of people, and all of which can cause disease—respectively, ulcers, TB, glandular fever (or worse, Burkitt's lymphoma), and cold sores. However, only a relatively small proportion of those infected actually develop these disorders. This means that other factors must determine the outcome of (or susceptibility to) infection, that is, whether the agent actually infects the person and whether it causes severe illness, or whether the consequences are mild or even asymptomatic. Obviously, it is important to determine just what these factors are, so that the interactions of the pathogen with the factor(s) can be investigated, thus enabling future strategies of prevention and treatment to be devised. In the case of our research on Alzheimer disease, our data indicate that HSV1 in brain of ApoE-e4 carriers confers a high risk of AD, accounting for the disease in about 60 percent of patients (Itzhaki et al., 1997; Lin et al., 1998). (I stress the fact that it is HSV1 residence in brain that is relevant to AD, and stress also that this is not revealed by serology; the latter would show simply if the virus is resident in the PNS—which it is, in almost all adults—but it tells us nothing about viral presence or absence in brain.)

    We have recently found that ApoE determines the outcome of infection in several quite diverse diseases definitely caused by microorganisms; the most clear examples perhaps are HSV1-induced cold sores, and hepatitis C virus-induced damage in the liver (Itzhaki et al., 1997; Wozniak et al., 2002), while Beth Corder et al. (1998) have shown the likelihood of dementia is greater in HIV-infected ApoE-e4 carriers. These findings, of course, provide strong, even if indirect, support for our suggested mechanism of virus-ApoE interaction in AD—competition for entry into cells (the extent depending on the isoform and probably on cell type too). The paper by Gerard et al. (2005) cited by Brian indicates an interaction of ApoE with Chlamydia, also. There are other types of evidence also that indirectly support the role of infectious agents in AD, including epidemiologic data on the effects of systemic infection on brain, work (including ours) linking HSV1 and APP or Aß (for references see Itzhaki et al., Neurobiol. Aging, 2004, and Shipley et al., 2005; Wozniak et al., in preparation), and a study showing that brain inflammation is augmented in mice with preclinical prion disease (Combrinck et al., 2002).

    Our HSV1-AD studies are sometimes misinterpreted as suggesting that AD patients are more susceptible to infection of brain by HSV1, that is, that the virus is present there just as a consequence of the disease rather than a causal factor. This is not the case, as shown clearly by the fact that the proportion of elderly controls with the virus in brain is similar to that of the AD sufferers. ApoE-e4 carriage is the deciding factor.

    Lastly, everybody must agree that new and seemingly "heretical" ideas and results need to be substantiated by others. However, that is an almost impossible requirement if most funding bodies refuse to support "non-mainstream" innovative work. AD patients and many others in future might question the wisdom of those who decide against or actively oppose such studies—especially studies on infectious agents, as these would lead to immediate therapeutic (and possibly to preventive) measures against the disease.


    . Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience. 2002;112(1):7-11. PubMed.

    . HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med. 1998 Oct;4(10):1182-4. PubMed.

    . The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog. 2005 Jul-Aug;39(1-2):19-26. PubMed.

    . Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 1997 Jan 25;349(9047):241-4. PubMed.

    . Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging. 2004 May-Jun;25(5):619-27. PubMed.

    . Herpes simplex virus interferes with amyloid precursor protein processing. BMC Microbiol. 2005;5:48. PubMed.

    . Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology. 2002 Aug;36(2):456-63. PubMed.

  3. Reply to Massimo Stefani by Brian Balin

    Dr. Stefani has responded to the background article with objections to arguments made in support of the pathogen hypothesis. While he admits that the microbial origin must be taken into consideration for some forms of late-onset AD (LOAD), his principal objections focus on evidence supporting familial forms of AD and other neurodegenerative diseases, and the cytotoxic effects of aggregated proteins in neurodegenerative diseases. Certainly, there exist familial forms of many neurodegenerative diseases. However, most of these are in the minority compared to sporadic forms, and can be attributed to defined mutations in different genes resulting in mutated proteins at risk for forming apparently toxic aggregates.

    What does this infer for our arguments invoking a pathogen hypothesis? The particular vulnerable genes and proteins at risk have been and are being identified through molecular analysis. This provides a knowledge base that strengthens our understanding of which parts of the cell are vulnerable to environmental influences, including infection. For example, knowing that the β amyloid precursor protein is vulnerable to increased production and processing, and that Aβ is susceptible to aggregation and deposition, is extremely valuable for assessing influences on this protein even in its unmutated state. Given that everyone produces and processes the amyloid precursor protein, at low levels, into the different Aβ peptides that accumulate in the AD brain, there could be numerous influences on cells in the central nervous system to increase production and breakdown of the amyloid precursor protein into β amyloid. Agreeably, these influences do not necessarily have to be infectious. However, infectious triggers may very well be at work as has been stated in the background.

    This implies that amyloidogenesis could be the trigger for AD. Once the initiating events have started, if there is no interruption of the triggering mechanism, then amyloidogenesis continues. If we accept the premise that aggregation and deposition of amyloid is toxic to brain cells, then as accumulation occurs, the brain responds. This would likely be observed as neuroinflammation wherein activation of glial cells results in increased secretion of inflammatory modulators such as reactive oxygen species, cytokines, and matrix metalloproteinases, to name a few. The result is increased nerve cell damage, increased amyloidogenesis, and exacerbation of the neuroinflammatory response. While this could help explain why aspects of autoimmune disease have been correlated with Alzheimer disease, we should also remember that autoimmunity can be caused by molecular mimicry, where proteins from an infectious agent elicit an immune reaction against highly homologous endogenous proteins. Heat shock proteins from Chlamydia pneumoniae, for example, can provoke an autoimmune response against human heat shock proteins.

    In essence, what may very well be happening could be the neurodegeneration equivalent of Knudson's "two-hit" hypothesis of oncogenesis, whereby the trigger (in this case, infection) is the "first hit," and the aggregation and deposition of amyloid becomes the "second hit." Obviously, this could be applied to any triggering stimulus resulting in a prolonged increase in amyloidogenesis. In this manner, the arguments made by Dr. Stefani, actually fit that of our hypothesis that infection can stimulate or trigger early events (including inflammation), resulting in structurally modified proteins that then feed back into the system.

    Furthermore, depending on the stimulus, be it infectious or toxic, for example, there may be numerous proteins that are vulnerable to damage and/or misfolding as the cellular machinery influencing the primary, secondary, and tertiary structures of these proteins may be directly affected. One cannot assume that there is no exogenous influence on this system. A prime example of this comes from our understanding of how the human papilloma virus causes cervical cancer. There are two gene products from certain strains of the virus that affect the retinoblastoma protein and p53. By disrupting the normal proteins, the cells are unable to control cell cycling and DNA repair, respectively, and cancer is the outcome. An analysis of the proteins shows that they were vulnerable to damage and dysfunction. Interestingly, other forms of cancer involve these very same proteins (pRB and p53), but the circumstances are that the proteins are abnormal because of gene mutations. Thus, two different etiologies, infection and mutation, demonstrate the vulnerability of the very same proteins, and both result in cancer.

  4. More Borrelia and Alzheimer disease

    The initial reports of recovery of Borrelia spirochetes from Alzheimer autopsy tissues (MacDonald, 1986; MacDonald and Miranda, 1987; and 1989, "Demonstration of a Spirochetal Cyst Form," Annals of the New York Academy of Sciences) were all spurned by the Alzheimer disease research establishment and ridiculed by such learned and distinguished scientists as Peter Davies, Dennis Dickson, and Willy Burgdorfer. Judith Miklossy, commencing in 1993 and continuously to the present has produced an astonishing series of landmark contributions to the neuropathology literature on borreliosis and Alzheimer disease showing recovery of Borrelia spirochetes from laboratory cultures of autopsy Alzheimer brain tissues, and the identification of Borrelia spirochetes in Alzheimer brain tissues using monoclonal antibodies specific for Borrelia. MacDonald and Miklossy have respectfully submitted two of Koch's postulates for consideration to support an infection, as a root cause for a subset of Alzheimer disease.

    The model of general paresis is the intellectual basis for consideration of the Borrelia infection subset of Alzheimer disease. It is pertinent to note that Hideyo Noguchi, in 1913, overturned centuries of conventional wisdom about the mistaken prevailing truth which stated that there was no etiologic relationship between syphilis infection in early life and general paresis dementia late in life. Syphilis is protean in its manifestations. Not every patient with untreated syphilis develops every possible tertiary manifestation. Only 12 of Noguchi's 70 autopsy brains in his 1913 paper yielded microscopic profiles of tissue treponema pallidum, and this "level of proof" would certainly fail to convince the establishment in 2005 that Dr. Noguchi "might be on to something." So let us vote right now, in the year 2005, on the following question. Was Noguchi correct about his view on the nature of general paresis? And if the vote is affirmative for Noguchi's contributions to our collective understanding of the treponemal pathogenesis of general paresis dementia, then why not revisit the works of Miklossy and MacDonald, who, like Noguchi, looked into their microscopes and saw a spirochetal pathogen at the site of a dementing disease.



    . Borrelia in the brains of patients dying with dementia. JAMA. 1986 Oct 24-31;256(16):2195-6. PubMed.

    . Concurrent neocortical borreliosis and Alzheimer's disease. Hum Pathol. 1987 Jul;18(7):759-61. PubMed.

  5. As a member of the SfN, we submitted a mini-symposium for the 2006 conference on the possible pathogenesis of Alzheimer's as a consequence of latent infectious agents, and of course were turned down. I was familiar with Alan MacDonald's, Judith Miklossy's, Brian Fallon's work and the Loeb Abx clinical trial. See below:

    Treatment with two antibiotics, doxycycline and rifampin, may curb cognitive decline in patients with symptoms of Alzheimer disease, suggest results of a study presented at the 41st Annual Meeting of the Infectious Disease Society of America (IDSA) in San Diego. The findings fuel the belief that infection is involved in the development of Alzheimer disease. "These two antibiotics have high activity against Chlamydia pneumonia, which is theorized to play a role in Alzheimer's disease," said Dr. Mark B. Loeb from McMaster University.

    We had seen a number of patients with Alzheimer's who gained temporary benefit from 5000 gauss DC EMF therapy who also live in an endemic area for Lyme. We submitted this abstract: Madrid 2006:

    P3-454 Electromagnetic field therapy in Alzheimer’s disease using DC electromagnetic field therapy: A pilot study, review of the literature, hypothesis of therapeutic action and future research proposal. Alzheimer's and Dementia, Volume 2, Issue 3, Pages S509-S510. T. Nichols, L. Pearce, D. Bonlie.

    See also:
    Cystic borrelia in Alzheimer’s disease and in non-dementia neuroborreliosis. Alzheimer's and Dementia. 2(3):S433-S433.

    Concurrent Neocortical Borreliosis and Alzheimer's Disease: Demonstration of a Spirochetal Cyst form. Ann N Y Acad Sci. 1989.


    . Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis. 2004 Dec;6(6):639-49; discussion 673-81. PubMed.

    . Transfection "Junk" DNA - a link to the pathogenesis of Alzheimer's disease?. Med Hypotheses. 2006;66(6):1140-1. PubMed.

    . Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete. Med Hypotheses. 2006;67(3):592-600. Epub 2006 May 3 PubMed.

    . A life cycle for Borrelia spirochetes?. Med Hypotheses. 2006;67(4):810-8. PubMed.

    . Spirochetal cyst forms in neurodegenerative disorders,...hiding in plain sight. Med Hypotheses. 2006;67(4):819-32. PubMed.

    . Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes. Med Hypotheses. 2007;68(4):822-5. PubMed.

    . Alzheimer's disease Braak Stage progressions: reexamined and redefined as Borrelia infection transmission through neural circuits. Med Hypotheses. 2007;68(5):1059-64. PubMed.

    . Concurrent neocortical borreliosis and Alzheimer's disease. Hum Pathol. 1987 Jul;18(7):759-61. PubMed.

    . Borrelia in the brains of patients dying with dementia. JAMA. 1986 Oct 24-31;256(16):2195-6. PubMed.

Make a Comment

To make a comment you must login or register.


Webinar Citations

  1. The Pathogen Hypothesis

Book page Citations

  1. Contact Us

Paper Citations

  1. . Herpes simplex virus type 1 and Alzheimer's disease. Neurobiol Aging. 1999 Jul-Aug;20(4):457-65. PubMed.
  2. . The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog. 2005 Jul-Aug;39(1-2):19-26. PubMed.
  3. . HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med. 1998 Oct;4(10):1182-4. PubMed.

External Citations

  1. Microbial Triggers of Chronic Human Illnesses

Further Reading

No Available Further Reading